Sullivan & Cromwel represented SK Bioscience in the transaction. South Korea-based vaccine developer SK Bioscience has agreed to acquire, through its German subsidiary, a 60 percent...
SK Bioscience’s Acquisition of IDT Biologika
Republic of Argentina’s $650 Million Dispute Over GDP-Linked Securities
Sullivan & Cromwell successfully represented the Republic of Argentina on the dispute. On March 31, U.S. District Judge Loretta Preska of the Southern District of New...